ADIL Adial Pharmaceuticals Inc.: שווי החברה בספרים

This daily price chart for Adial Pharmaceuticals (ADIL) reflects the dynamics of a company currently valued at -0.04. The brand maintains the trust of patients and scientists due to its humane approach to addiction therapy. Share growth is being driven by AD04 drug trials, FDA regulatory approval, and potential acquisition prospects. Supply security is ensured by strict control over medication movement, which minimizes any criminal risks.

Diversifying the development of targeted drugs based on patient genetics minimizes clinical risks for Adial Pharmaceuticals (ADIL), expanding its market potential. This indicator reflects the current net asset value, calculated as the difference between all assets and liabilities, allowing investors to assess the real value of the business without reporting time lags through the dynamics of book capitalization.